Lonza - About the company
Lonza is an acquired company based in Basel (Switzerland), founded in 1897. It operates as a Provider of CDMO services to pharma, biotech, and specialty ingredient markets. Lonza has raised an undisclosed amount in funding.
Company Details
Provider of CDMO services to pharma, biotech, and specialty ingredient markets. The company offers a complete range of development and manufacturing services for fine chemicals, advanced intermediates, active pharmaceutical ingredients (APIs), biologics, and functional ingredients. They claim to offer synergies between chemical synthesis and biotechnology to enable the production of tailor-made intermediates and APIs for use as pharmaceuticals, biotherapies, nutraceuticals, and cosmetics. Their proprietary platforms and development technologies such as GS Gene enable them to offer customized biological and chemical manufacturing solutions. In 2022, the company recorded annual revenues of $6.52B and a net profit of $1.27B.
- Email ID
- *****@lonza.com
- Registered Address
- Morristown, New Jersey
Key Metrics
Founded Year
1897
Location
Basel, Switzerland
Stage
Acquired
Latest Funding Round
Annual Revenue
£0 - £1M as on Aug 31, 2024
Employee Count
19,440 as on Sep 30, 2026
Exit Details
Acquired by SBI Mutual Fund (Feb 15, 2024)
Legal entities associated with Lonza
Lonza is associated with 10 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Manuscript Manufactory s.r.o. CIN: 17139422 , Czech Republic, Active | May 12, 2022 | - | - | |
Bomi Wood s.r.o. CIN: 02703581 , Czech Republic, Active | Feb 25, 2014 | - | - | |
LONZA FINANCE INTERNATIONAL NV CIN: 0736.673.428 , Belgium, Active | Oct 22, 2019 | - | - | - |
LONZA CIN: 40103809594 , Latvia, Deadpooled | Jul 21, 2014 | €0 - €1M (As on Dec 31, 2015) | 5 (As on Dec 31, 2015) | - |
LENZA WORLD LIMITED CIN: 12844264 , United Kingdom, Active | Aug 27, 2020 | £0 - £1M (As on Aug 31, 2024) | - | |
ARCH PROTECTION CHEMICALS PRIVATE LIMITED CIN: U74930MH2010FTC207485 , India, Active | Sep 07, 2010 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 33 (As on Aug 31, 2024) | |
Lonza India Private Limited CIN: U24230HR1999PTC095355 , India, Active | Jan 25, 1999 | 0 - ₹10 Cr (As on Mar 31, 2025) | - | |
CAPSUGEL HEALTHCARE PRIVATE LIMITED CIN: U85110HR1982PTC020151 , India, Active | Dec 13, 1982 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | - | |
Lonza Inc. CIN: 135665861 , United States, Active | Dec 26, 999 | - | 973 (As on Dec 31, 2024) | - |
Lonza Group CIN: CHE-106.841.866 , Switzerland, Active | $1B+ (As on Dec 31, 2022) | - | - |
Lonza's acquisition details
Lonza got acquired by SBI Mutual Fund on Feb 15, 2024.
Click here to take a look at Lonza's acquisition in detail
Sign up to download Lonza's company profile
Lonza's funding and investors
Lonza has raised funding over 6 rounds. Its first funding round was on Nov 09, 2010. Its latest funding round was a Post IPO round on Nov 25, 2023 for $*****. 1 investor participated in its latest round. Lonza has 7 institutional investors.
Here is the list of recent funding rounds of Lonza:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 25, 2023 | 5105386 | Post IPO | 1110085 | 9820988 | 5511014 | 1050451 |
May 12, 2022 | 3234362 | Post IPO | 2182200 | 4322815 | 5646945 | |
Jan 01, 2019 | 7867929 | Grant (prize money) | 1572141 | 5723584 | 2639569 |
View details of Lonza's funding rounds and investors
Lonza's founders and board of directors
Founder? Claim ProfileLonza's employee count trend
Lonza has 19,440 employees as of Sep 26. Here is Lonza's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Lonza's Investments and acquisitions
Lonza has made 4 investments in companies including Affinia Therapeutics and Affinia Therapeutics. Lonza has also acquired 13 companies including Synaffix and Octane.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 01, 2023 | Acquisition | 2010 | Nijmegen (Netherlands) | |
Apr 20, 2021 | Investments | 2019 | Waltham (United States) | |
Mar 12, 2020 | Investments | 2019 | Waltham (United States) |
See all investments and acquisitions by Lonza
Reports related to Lonza
Here is the latest report on Lonza's sector:
News related to Lonza
Media has covered Lonza for a total of 58 events in the last 1 year, 33 of them have been about company updates and 8 about partnerships.
•
•
Lonza and Onava Partner on AI Biologics Pact to Accelerate Drug DiscoveryContract Pharma•Oct 09, 2026•ONAVA, Lonza
•
Lonza and Asimov Partner to Advance Scalable Lentiviral Vector ManufacturingContract Pharma•Oct 02, 2026•Asimov, Lonza
•
Lonza Advances Aseptic Spray Drying Platform for High-Dose BiologicsContract Pharma•Oct 01, 2026•Lonza
•
•
Lonza Capsugel Launches New Service for Nitrite Testing and Risk Management in Empty CapsulesEuropean Pharmaceutical Manufacturer•Sep 28, 2026•Lonza
•
Qurient files international patent for dual-payload ADC platform technologyNewswire•Sep 28, 2026•Qurient, Lonza
•
Lonza Expands US Presence with New Commercial Spray-Drying Facility in Bend, OregonChemanager Online•Sep 10, 2026•Lonza
•
•
Lonza Launches Rapid Media Prototyping Service to Accelerate Biopharmaceutical DevelopmentBlogarama•Aug 19, 2026•Lonza
Are you a Founder ?
FAQs about Lonza
Explore our recently published companies
- Captain - Montreal based, 2021 founded, Unfunded company
- Navigo - Delhi based, 2024 founded, Unfunded company
- Skynext - Mumbai based, 2020 founded, Unfunded company
- Digital Maker - Peterhead based, 2017 founded, Unfunded company
- Byteport - San Francisco based, 1999 founded, Seed company
- Back Benchers - India based, 2024 founded, Unfunded company